featured news

October 29, 2025

Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws

October 28, 2025

Berger Montague PC Investigates KinderCare Learning Companies, Inc.’s Board of Directors for Breach of Fiduciary Duties (NYSE: KLC)

October 23, 2025

A Big Pro Bono Win for Student Borrowers in Income Driven Repayment (IDR) Programs

December 10, 2014 General

Eleventh Circuit Tackles Contentious Rule 9(b) Issue

As we have reported in a previous post, Florida-based Health Management Associates, Inc. is facing extreme liability under the False Claims Act stemming from allegations that emergency room physicians were offered kickbacks and financial incentives for admitting a certain number of patients per day – notwithstanding the lack of medical […]

#Eleventh Circuit #Federal Rule of Civil Procedure 9(b) #Rule 9(b) #US Court of Appeals

Contact UsFree Case Evaluation

"*" indicates required fields

First Name*

Last Name*

Email Address*

Phone Number*

Practice Area

City*

State*

Please describe your potential case or matter.**

By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.

featured investigations

Six Flags Entertainment Securities Fraud Investigation

Investigation Deadline: January 5, 2026

Status: Pending
Under Investigation
Securities Fraud & Investor Protection

A class action lawsuit was filed against Six Flags Entertainment Corp. (NYSE: FUN) on behalf of investors who purchased or acquired Six Flags shares from July 1, 2024 through November 5, 2025 (the...

join the case

Fiserv Securities Fraud Investigation

Investigation Deadline: January 5, 2026

Status: Pending
Under Investigation
Securities Fraud & Investor Protection

A class action lawsuit was filed against Fiserv, Inc. (NYSE: FI) on behalf of investors who purchased Fiserv shares during the period of July 23, 2025 through October 29, 2025 (the “Class...

join the case

Akero Therapeutics, Inc. Breach of Fiduciary Duties...

Status: Pending
Securities Fraud & Investor Protection

Berger Montague is investigating Akero Therapeutics and its board of directors for potential breaches of fiduciary duties and violations of the federal securities laws. Headquartered in San Francisco,...

join the case

$2.4B+

in 2025 post-trial judgments

$50B+

in Settlements & Verdicts

55+

Years of Experience With High-Profile Cases

100+

Attorneys Protecting Your Rights

20+

Years Ranked as Top Law Firm by Chambers USA

States in Which The Firm Has Successfully Litigated